The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2017.08.026

PubMed Identifier: 28987811

Publication URI: http://europepmc.org/abstract/MED/28987811

Type: Journal Article/Review

Volume: 141

Parent Publication: The Journal of allergy and clinical immunology

Issue: 1

ISSN: 0091-6749